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Abstract
Aims/hypothesis Cataract surgery in diabetic individuals worsens pre-existing retinopathy and triggers the development of
diabetic ocular complications, although the underlying cellular and molecular pathophysiology remains elusive. We hypothesise
that lens surgery may exaggerate pre-existing retinal inflammation in diabetes, which may accelerate neurovascular degeneration
in diabetic eyes.
Methods Male heterozygous Ins2Akita mice (3 months of age) and C57BL/6 J age-matched siblings received either lens
capsulotomy (to mimic human cataract surgery) or corneal incision (sham surgery) in the right eye. At different days post surgery,
inflammation in anterior/posterior ocular tissues was assessed by immunohistochemistry and proinflammatory gene expression
in the retina by quantitative PCR (qPCR). Degenerative changes in the retina were evaluated by electroretinography, in vivo
examination of retinal thickness (using spectral domain optical coherence tomography [SD-OCT]) and morphometric analysis of
retinal neurons. The therapeutic benefit of neutralising Wnt/β-catenin signalling following lens capsulotomy was evaluated by
intravitreal administration of monoclonal antibody against the co-receptor low-density lipoprotein receptor-related protein 6
(LRP6) (Mab2F1; 5 μg/μl in each eye).
Results Lens capsulotomy triggered the early onset of retinal neurodegeneration in Ins2Akita mice, evidenced by abnormal
scotopic a- and b-wave responses, reduced retinal thickness and degeneration of outer/inner retinal neurons. Diabetic Ins2Akita
mice also had a higher number of infiltrating ionised calcium-binding adapter molecule 1 (IBA1)/CD68+ cells in the anterior/
posterior ocular tissues and increased retinal expression of inflammatory mediators (chemokine [C-Cmotif] ligand 2 [CCL2] and
IL-1β). The expression of β-catenin was significantly increased in the inner nuclear layer, ganglion cells and infiltrating immune
cells in Ins2Akita mice receiving capsulotomy. Neutralisation of Wnt/β-catenin signalling by Mab2F1 ameliorated ocular inflam-
mation and prevented capsulotomy-induced retinal degeneration in the Ins2Akita mouse model of diabetes.
Conclusions/interpretation Targeting the canonical Wnt/β-catenin signalling pathway may provide a novel approach for the
postoperative management of diabetic individuals needing cataract surgery.
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Abbreviations
BRN3A POU domain, class 4, transcription factor 1
ERG Electroretinography
GCL Ganglion cell layer
GFAP Glial fibrillary acidic protein
GFP Green fluorescent protein
IBA1 Ionised calcium-binding adapter molecule 1
INL Inner nuclear layer
LRP6 Low-density lipoprotein receptor-related
protein 6
MFI Mean fluorescence intensity
NFL Nerve fibre layer
OPL Outer plexiform layer
POS Photoreceptor outer segments
qPCR Quantitative PCR
RGC Retinal ganglion cell
SD-OCT Spectral domain optical coherence
tomography
WT wild-type
Introduction
With an ageing population and the growing prevalence of
obesity due to increasingly sedentary lifestyles, the incidence
of diabetes mellitus is rising at an alarming rate [1]. One of the
common complications associated with diabetes is diabetic
retinopathy, which is the leading cause of vision loss in the
working-age population [2]. Diabetic retinopathy is a progres-
sive disorder that results in alterations in the neuroretina, lead-
ing to retinal neurodegeneration and microangiopathy in its
early stages [3]. Non-proliferative diabetic retinopathy can
lead to retinal non-perfusion, which ultimately drives patho-
logical intraocular neovascularisation, known as proliferative
diabetic retinopathy [4]. How diabetes leads to diabetic reti-
nopathy is still not fully understood; however, inflammation is
known to play an important role in its development and pro-
gression [5]. Other ocular complications associated with dia-
betes include cataract and corneal diseases [6]. Cataract is the
leading cause of blindness worldwide and one of the major
factors responsible for vision impairment [7].
Clinical studies have shown a clear link between diabetes
and cataract formation [8]. Diabetic individuals tend to devel-
op cataracts prematurely and progression is more rapid com-
pared with people without diabetes [9, 10]. Owing to the rising
prevalence of diabetes, the incidence of diabetic cataracts is
also increasing [10]. Although cataract surgery is a routine
procedure, it is not without risk. There is mounting evidence
linking the development and/or exacerbation of pre-existing
diabetic retinopathy following cataract surgery. Individuals
who already have pre-existing active proliferative retinopathy
and/or macular oedema tend to have the poorest outcomes
following cataract surgery, such as a significant decrease in
visual acuity and fast progression of diabetic retinopathy [11].
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Phacoemulsification, the most common clinical procedure for
cataract surgery, is shown to accelerate the progression of
diabetic retinopathy in 34–50% of individuals [12–14], and
induces macular oedema in 25–55% of diabetic individuals
[15, 16]. The molecular mechanism underlying cataract-
surgery-mediated worsening of diabetic retinopathy remains
poorly defined, resulting in the absence of established guide-
lines for this ocular complication.
Previous investigations suggest a link between cataract sur-
gery and exacerbation of ocular inflammation [17, 18]. For
example, extracapsular lens extraction is shown to upregulate
the expression of proinflammatory genes in the murine retina,
including Ccl2 and Il-1β (also known as Il1b) [19]. This can
be problematic when considering the immunoprivileged status
of the retina, as inflammatory mediators may actively drive
retinal neurodegeneration [20]. Nevertheless, it remains un-
clear whether cataract-surgery-mediated worsening of diabetic
retinopathy is elicited by exacerbation of retinal inflammation.
Activation of the canonical Wnt/β-catenin signalling path-
way has been previously reported in diabetic retinopathy and
its associated complications [21]. Besides its well-known role
in embryonic development, Wnt/β-catenin activation is
known to exert proinflammatory functions [22, 23]. For ex-
ample, retinal microglia treated with recombinant Wnt3A (li-
gand for the canonical Wnt pathway) induced the expression
and release of proinflammatory cytokines, including IL-6, IL-
12 and TNF-α [22], demonstrating a regulatory role for Wnt
signalling in retinal macrophage activation.
Extracapsular lens extraction is rarely performed in diabetic
individuals. Phacoemulsification and intraocular lens implan-
tation cannot be performed in mouse eyes. In this study, we
performed lens capsulotomy to mimic two components of
human cataract surgery in a murine model of type 1 diabetes
(Ins2Akita mouse): (1) a surgery at the anterior part of the eye
with minimal traumatic insults; and (2) the release of lens
protein into the anterior chamber of the eye. We then investi-
gated the associated ocular immune and retinal degenerative
pathogenesis.
Methods
AnimalsMale heterozygous Ins2Akitamice of C57BL/6 J back-
ground (C57BL/6-Ins2Akita/J, Jackson Laboratory, Bar
Harbor, ME, USA) and non-diabetic siblings were used. The
Ins2Akita mice develop severe hyperglycaemia (>13.9mmol/l)
by 4 weeks of age [24]. Cx3cr1GFP/GFP and C57BL/6 J mice
were bred to obtain heterozygous Cx3cr1+/GFP mice (which
show green fluorescent protein [GFP]+ monocyte-derived
cells but not chemokine [C-X3-C motif] receptor 1
[CX3CR1] deficiency). Mice were housed in standard
pathogen-free animal housing rooms with 12/12 h light/dark
cycle and free access to food and water. All procedures were
conducted following the Guide for the Care and Use of
Laboratory Animals and the regulation of the UK Home
Office Animals (Scientific Procedures) Act 1986. Animal ex-
periments followed the guidelines of the Association for
Research in Vision and Ophthalmology (ARVO) on the use
of animals in ophthalmic and vision research.
Lens capsulotomy surgery The traditional cataract surgery,
extracapsular lens extraction, induces rapid posterior capsule
opacification in mice [25], which prevents further investiga-
tion of diabetic retinopathy. We therefore conducted lens
capsulotomy in 3-month-old mice (this age was kept constant
for all experimental groups and strains across the study) to
mimic human cataract surgery. Mice were anaesthetised by
isoflurane and pupils dilated with 1% (wt/vol.) tropicamide
and 2.5% (wt/vol.) phenylephrine (Laboratoire Chauvin,
Montpellier, France).
A schematic representation of the capsulotomy procedure
is shown in electronic supplementary material (ESM) Fig. 1.
Briefly, a 1 mm incision was performed in the peripheral cor-
nea and 1% sodium hyaluronate (wt/vol.; Bohus-BioTech,
Strömstad, Sweden) administered into the anterior chamber.
Capsulotomy was performed in the right eye by cutting the
anterior lens capsule using standard micro-scissors. The cor-
neal wound was sutured and topical 2.5% phenylephrine (wt/
vol.) /1% atropine administered (wt/vol.). Control mice re-
ceived corneal incision without capsulotomy in the right eye.
Fundus imaging following capsulotomy confirmed the ab-
sence of retinal detachment, which may result from corneal
puncture [26] (ESM Fig. 1c). Animals showing signs of eye
atrophy or anterior chamber/vitreous haemorrhage were ex-
cluded from the study. The capsulotomy healed within 1 week
of surgery and none of the animals developed lens
opacification in the long term (although transient cloudiness
was observed for up to 10–15 days). Age-matched mice not
receiving capsulotomy or corneal incision served as full con-
trols. Wild-type (WT), Ins2Akita and Cx3cr1+/GFP mice were
randomly assigned (using a simple randomisation method) to
each surgery group. No specific blinding was carried out to
outcome assessment.
Intraocular administration of anti-LRP6 co-receptor antibody
Blockade of the canonical Wnt signalling pathway was per-
formed via administration of mouse monoclonal antibody
against the Wnt low-density lipoprotein receptor-related pro-
tein 6 (LRP6) co-receptor (Mab2F1) [27]. Mab2F1 has shown
to efficiently reduce the bio-activity of canonical Wnt signal-
ling in rodent eyes at a dose of 20 μg/eye [27]. The surface of
mouse retina (5.6 mm2) is approximately one-quarter that of
rat retina (52 mm2) [28]. Therefore, we injected 5 μg/μl
MabF1 into mouse eyes. To avoid additional insults from
intravitreal injection, 1 μl Mab2F1 (5 μg/μl) or endotoxin-
free mouse IgG (5 μg/μl) (MyBioSource, San Diego, CA,
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USA) in 0.01 mol/l PBS was injected into the anterior cham-
ber immediately after capsulotomy, using a 33 gauge needle
(Hamilton-Bonaduz, Bonaduz, Switzerland) cannulated
through the sutured wound. Twenty days after capsulotomy,
1 μl Mab2F1 or mouse IgGwas administered into the vitreous
chamber as previously described [29]. Mab2F1 or IgG treat-
ments were conducted in two separate experiments (n ≥ 5
mice per study/group). Age-matched mice not receiving any
intravitreal injections served as full controls (n ≥ 5 mice per
strain).
Clinical investigations Fundus images were obtained as previ-
ously described [29]. For spectral domain optical coherence
tomography (SD-OCT) (n = 7mice forWT full controls; n = 5
mice for remaining WT and Ins2Akita groups), animals were
anaesthetised with ketamine/xylazine (90 mg 10 mg−1 kg
body weight−1) and examinations conducted 40 days follow-
ing capsulotomy (to ensure a prudent duration for the devel-
opment of retinal degeneration) using the Spectralis
Heidelberg OCT system (Heidelberg Engineering,
Heidelberg, Germany). Retinal thickness (from nerve fibre
layer [NFL] to the photoreceptor outer segments [POS]) was
measured at 600 μm eccentricities from the optic disc in
dorso–ventral and nasal–temporal sectors.
Electroretinography Electroretinography (ERG) responses
were recorded 40 days following eye surgery (n = 7 mice for
WT and Ins2Akita full controls; n = 5 mice for remaining WT
and Ins2Akita groups) as previously described [30, 31].
Scotopic ERGs were taken using mouse corneal ERG elec-
trodes, in response to single white light flashes of different
intensities, delivered by a standard Ganzfeld Stimulator
(LKC Technologies, Gaithersburg, MD, USA). The ampli-
tudes and implicit times of the scotopic a- and b-waves were
obtained.
qPCRTotal RNAwas isolated frommouse retinas 14 days after
surgery (n = 8 eyes for WT full control; n = 6 Ins2Akita
capsulotomy; n = 5 for WT and Ins2Akita remaining groups)
using the RNeasy Mini Kit (Qiagen, Crawley, UK).
Quantitative PCR (qPCR) was performed using SYBR
Green Master (Roche Diagnostics, Mannheim, Germany) in
a LightCycler 480 system (Roche Diagnostics). The relative
expression levels of target genes (Vegfa, iNos [also known as
Nos2], Il-1β andCcl2) were normalised toβ-actin. The primer
sequences used in this study are listed in ESM Table 1.
Immunoblotting Ten days after surgery (n = 3 eyes/group),
retinas were harvested and lysed in RIPA buffer, with protease
inhibitor and phosphatase inhibitor cocktails (Sigma-Aldrich,
Gillingham, UK). Eluted proteins samples (20 μg) were run
on 10% (wt/vol.) SDS-PAGE gels. Samples were probed
using rabbit anti-β-catenin (1:2000; Cell Signaling
Technology, Danvers, MA, USA) and protein levels com-
pared with β-actin (1:10,000, Santa Cruz Biotechnology,
Dallas, TX, USA). Antibodies were validated by the manu-
facturers for western blot analysis (ESM Table 2).
Immunohistochemistry and histology Enucleated globes were
dissected and fixed in 2% (wt/vol.) paraformaldehyde and
processed for immunohistochemistry as previously described
[32]. Retinal sections were stained with primary antibodies
(validated by the manufacturers for immunofluorescence anal-
yses [ESM Table 2]) and examined by confocal microscopy
(C1-Nikon-Eclipse TE200-U, Nikon UK, Kingston upon
Thames, UK). Some retinal sections were processed for
H&E staining and examined by light microscopy (Nikon-
Eclipse E400 light microscope; Nikon UK).
Confocal morphometry Confocal images acquired under con-
stant photomultiplier settings were used for morphometric
analysis of retinal neurons, immune cell subsets, Wnt/β-
catenin activation, glial fibrillary acidic protein (GFAP)-reac-
tive gliosis and albumin leakage. Images (n = 3 mice/group; 2
retinal sections/eye; 4 images/section) were analysed using
FIJI software (National Institutes of Health, Bethesda, MD,
USA). Morphometric analysis of retinal neurons was conduct-
ed as previously described [29, 30]. For a detailed procedure
of each morphometric analysis, please refer to the ESM
Methods.
StatisticsERG scotopic responseswere analysed using two-way
ANOVA followed by Bonferroni’s post-hoc analysis. SD-OCT
retinal thickness and morphometric data in each mouse strain
were analysed by one-way ANOVA, followed by Bonferroni’s
post hoc analysis using GraphPad Software (La Jolla, CA,
USA). Significant outliers in qPCR analysis were identified
and discarded using Grubbs’ test (α = 0.05, GraphPad). No out-
liers were detected in the neuronal and immune cells morpho-
metric analysis. Data were expressed as mean ± SEM and p <
0.05 was considered statistically significant.
Results
Retinal degeneration and scotopic electroretinogram re-
sponses following capsulotomy SD-OCT analysis revealed
no major retinal morphological abnormalities in WT and
Ins2Akita mice at 40 days following corneal incision (data not
shown) or capsulotomy (Fig. 1b). However, the overall retinal
thickness (from the NFL to POS) was significantly reduced in
Ins2Akita corneal incision and capsulotomy groups compared
with Ins2Akita full controls and with their WT counterparts
(Fig. 1b).
Scotopic ERG showed a significant decrease in a-wave
amplitudes at higher flash intensities (1, 1.5 log10 cd × s/m
2)
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in WT mouse eyes 40 days following corneal incision or
capsulotomy compared with full control WT eyes (Fig. 1c,
e). No significant differences were observed in the amplitude
of b-waves (Fig. 1g) or implicit times of a- and b-waves (Fig.
1i, k). In Ins2Akitamice, a significant reduction in a-wave (Fig.
1f) and b-wave amplitudes (Fig. 1h) was observed in corneal
incision (1, 1.5 log10 cd × s/m
2) and capsulotomy (1, 1.5 log10
cd × s/m2) eyes 40 days after surgery compared with full con-
trol Ins2Akita eyes. The implicit times of a-waves (Fig. 1j) and
b-waves (Fig. 1l) were significantly delayed in capsulotomy
but not in corneal incision eyes compared with full control
eyes and with WT capsulotomy eyes. Overall, these data sug-
gest a greater impairment of retinal electrophysiology follow-
ing capsulotomy in diabetic eyes.
Retinal neurodegeneration is worsened in Ins2Akita diabetic
eyes following capsulotomy To understand how retinal integ-
rity was affected by capsulotomy, outer and inner neuronal
Fig. 1 Retinal degeneration and abnormal scotopic ERG responses fol-
lowing capsulotomy. (a) Three-month-old WT and Ins2Akita mice
underwent corneal incision or lens capsulotomy and eyes were assessed
40 days after surgery for retinal degeneration. The red areas on the image
show the positions where corneal incision and capsulotomy were per-
formed (for a more detailed schematic see ESM Fig. 1). (b)
Representative SD-OCT images from WT or Ins2Akita mice following
corneal incision or capsulotomy. The quantitative analysis of neuroretinal
thickness by SD-OCT (from the photoreceptor inner segments/outer seg-
ments [IS/OS] to NFL) highlights significant retinal degeneration
resulting from ocular surgery in Ins2Akita mice. White bars, full control;
light grey bars, corneal incision; dark grey bars, capsulotomy. (c, d)
Representative scotopic ERG responses from WT (c) and Ins2Akita (d)
mice of different treatment groups, as indicated. (e–l) The amplitude (μV)
and implicit time (ms) of a-waves and b-waves in WT (e, g, i, k) and
Ins2Akita (f, h, j, l) mice (n = 7 mice for WT full controls; n = 5 mice for
WTand Ins2Akita remaining groups). ERG white light flashes are present-
ed as log10 cd × s/m
2. In (e–l): solid line, full control; dashed line, corneal
incision; dotted line, capsulotomy. Results are presented as mean ± SEM.
*p < 0.05, **p < 0.01 and ***p < 0.001 for capsulotomy compared with
full control mice of the same strain. †p < 0.05, ††p < 0.01 and †††p < 0.001
for WT vs Ins2Akita capsulotomy groups. ‡p < 0.05, ‡‡p < 0.01 and ‡‡‡p <
0.001 for corneal incision compared with full control mice of the same
strain. One-way ANOVA in (b) and two-way ANOVA in (e–m)
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cell populations were characterised 40 days following surgery.
A significant reduction in the length of cone photoreceptor
segments was observed in Ins2Akita mice following
capsulotomy (cone arrestin; Fig. 2a–d, q), which was accom-
panied by substantial cone photoreceptor outer segment frag-
mentation (arrowheads in Fig. 2d). In addition, a significant
depletion of horizontal cell dendritic boutons was evident in
Ins2Akita mice receiving capsulotomy (calbindin; Fig. 2e–h, r
[see arrowheads in h]).
At the inner retina, the density of amacrine cells
(GABAergic + glycinergic) was significantly decreased in
both corneal incision and capsulotomy WT groups compared
with full control mice (Fig. 2i–j, s). Capsulotomy-induced
amacrine cell loss was more severe than corneal-incision-
induced amacrine loss in Ins2Akita mice (Fig. 2k–l, s). The
surgery did not affect retinal ganglion cells [RGCs] positive
for POU domain, class 4, transcription factor 1 (BRN3A) in
WT mice (Fig. 2m–n, t), but significantly reduced the RGC
number in Ins2Akita mice (Fig. 2o–p, t).
Ocular inflammation is exacerbated in Ins2Akita diabetic eyes
following capsulotomy Immunohistochemistry revealed a sig-
nificant increase in the number of ionised calcium-binding
adapter molecule 1 (IBA1)+ CD68+ cells in the irido–corneal
Fig. 2 Retinal neurodegeneration in WT and Ins2Akita mice after
capsulotomy. Three-month-old WT (a,b,e,f,i,j,m,n) and Ins2Akita
(c,d,g,h,k,l,o,p) mice underwent corneal incision or lens capsulotomy.
At 40 days after the procedure, eyes were assessed for neuronal degener-
ation by immunohistochemistry. (a–p) Retina photomicrographs of cone
photoreceptors (a–d; cone arrestin), horizontal cells (e–h; calbindin),
amacrine cells (i–l; red channel, GABA; green channel, glycine transport-
er 1) or RGCs (m–p; BRN3A) of WT and Ins2Akita treatment groups. (d)
Cone segment disruption (cone arrestin+ particles free from cone outer
segments [arrowheads]) in Ins2Akita capsulotomy eyes. (h) Loss of hori-
zontal cell synaptic boutons (arrowheads) in Ins2Akita capsulotomy eyes.
(q–t) Quantitative analysis of (q) cone segment length (box 1 in a), (r)
horizontal cell synaptic boutons (box 2 in e), (s) GABAergic +
glycinergic amacrine cells (box 3 in i) and (t) BRN3A+ RGCs (box 4 in
m) in different treatment groups. White bars, full control; light grey bars,
corneal incision; dark grey bars, capsulotomy. n = 20 retinal images per
strain/condition. Results are presented as mean ± SEM. *p < 0.05, **p <
0.01 and ***p < 0.001 as shown. One-wayANOVA. Scale bars, 20μm in
(h) and 30 μm in (d, l, p). GABA, γ-aminobutyric acid; GlyT1, glycine
transporter 1; IPL, inner plexiform layer; IS, inner segment; ONL, outer
nuclear layer; OS, outer segment
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junction of WT and Ins2Akita mice 40 days following surgery
(sham and capsulotomy) (Fig. 3a). H&E staining revealed
giant pigmented cells at different ocular locations, including
the ciliary body region (arrowheads, Fig. 3a) which also
extended to the vitreo–retinal interface (arrowheads in Fig.
3c) and subretinal region (arrows in Fig. 3c).
In the retina, a time-dependent accumulation of IBA1+
cells was observed in WT and Ins2Akita mice following
Fig. 3 Ocular inflammation in WT and Ins2Akita mice after capsulotomy.
(a–f) Three-month-old WTand Ins2Akitamice underwent corneal incision
or lens capsulotomy. At 40 days after the procedure, eyes were assessed
for inflammation. (a) Immunoreactivities in the irido–corneal junction
(see diagram) of full control WT and Ins2Akita eyes or following
capsulotomy: red, CD68; green, IBA1. The H&E-stained light micro-
graph shows infiltrating pigmented cells in the vitreo–retinal border and
ciliary body (arrowheads); graph shows the area of IBA1/CD68 cells at
the irido–corneal junction in different groups. (b) IBA1 immunoreactivity
in retina (see diagram) of WT and Ins2Akita mice of different groups.
IBA1+ microglial cells were dispersed through all retinal layers following
capsulotomy (arrows); graph shows the density of IBA1+ cells in different
groups. (c) H&E-stained light micrographs and CD68 (red) and IBA1
(green) immunoreactivity of WT and Ins2Akita mouse retinas following
capsulotomy. Infiltration of CD68+ and IBA1+ immune cells in the
subretinal space (arrows) and in the vitro–retinal border (arrowheads).
The graph shows that a significant increase in IBA1/CD68 cells was
observed at the subretinal space and vitro–retinal border of WT and
Ins2Akita capsulotomy eyes. (d) GFAP immunoreactivity in middle eccen-
tricities of WT and Ins2Akita mouse retinas and the density of GFAP+
processes expanding from the GCL to the OPL (GCL-OPL) in different
treatment groups. (e–h) qPCR analysis of proinflammatory genes in the
retina of full controlWTor Ins2Akitamice 14 days after corneal incision or
capsulotomy. In (a–d): white bars, full control; light grey bars, corneal
incision; dark grey bars, capsulotomy. In (e–h): black circles, full control;
white circles, corneal incision; triangles, capsulotomy. In (a, d), n = 12
retinal images per strain/condition. In (b, c), n = 9 retinal sections per
strain/condition. In (e–h), n = 8 eyes for WT full control; n = 6 eyes for
Ins2Akita capsulotomy; n = 5 eyes for WTand Ins2Akita remaining groups.
Results are presented as mean ± SEM. *p < 0.05, **p < 0.01 and ***p <
0.001 as shown. One-way ANOVA. Scale bars, 20 μm in (c) both light
and fluorescence micrographs; 50 μm in (a, b, d). Caps, capsulotomy;
CB, ciliary body; corn inc, corneal incision; ctrol, control; IPL, inner
plexiform layer; ONL, outer nuclear layer; PS, photoreceptor segments;
Ret, retina; RPE, retinal pigment epithelium
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Fig. 4 Activation of the canonical Wnt/β-catenin signalling pathway in
ocular tissues following capsulotomy. (a) Lens capsulotomy was per-
formed in 3-month-old Cx3cr1+/GFP mice. After 10 days, eyes were proc-
essed for β-catenin immunostaining. (b–e) GFP+ monocyte-derived cells
showed nuclear accumulation of β-catenin in stromal cells at the irido–
corneal junction (arrow in b, with highmagnification images to the right),
and in cells infiltrating the vitreo–retinal interface (GCL; arrow in c, with
highmagnification images to the right) and subretinal space (PS; arrow in
d, with high magnification images to the right), but not in retinal
microglial cells (arrow in e, with high magnification images to the right).
(f–i) Lens capsulotomy was performed in 3-month-old WT and Ins2Akita
mice and eyes collected at different time points (1, 10 and 40 days) after
capsulotomy and processed for β-catenin immunostaining. (f)
Accumulation of β-catenin in the nucleus of stromal cells at the irido–
corneal junction. The confocal micrographs show accumulation of β-
catenin peaked by 10 days post surgery (arrowheads in high-
magnification inset). Graphs show the MFI of β-catenin in the nucleus
of stromal cells and the densities of cells accumulating low (solid line),
mid (dotted line) and high (dashed line) levels of nuclear β-catenin at
different post-surgery times in WT and Ins2Akita mice. (g) Retina micro-
graphs of β-catenin immunoreactivity in Ins2Akita in different treatment
groups. (h, i) TheMFI of β-catenin in the nucleus of INL (h, arrowheads)
and GCL (i, arrowheads), at different post-surgery times in different treat-
ment groups. In (h, i): solid line, WT; dashed line, Ins2Akita. n = 12
(sclero–corneal, f) and n = 20 (retina, h, i) images per strain, condition
and time point. Results are presented as mean ± SEM. *p < 0.05, **p <
0.01 and ***p < 0.001 compared with full control mice of same strain (as
fold change). One-way ANOVA. Scale bars, 30μm in (b–g), 20μm in (h,
i) and 10 μm in the high-magnification insets in (b–f). Ctrol, control; IPL,
inner plexiform layer; ONL, outer nuclear layer; PS, photoreceptor seg-
ments; OLM, outer limiting membrane
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capsulotomy (arrows in ESM Fig. 2). The IBA1+ microglia
were observed throughout all retinal layers from the NFL
to outer plexiform layer (OPL), and the number was sig-
nificantly higher in the WT and Ins2Akita mice that
underwent capsulotomy compared with full control eyes
(arrows in Fig. 3b). In addition, a significantly higher num-
ber of IBA1+ CD68+ cells at the subretinal space (arrows in
Fig. 3c) and vitreous–retinal border (arrowheads in Fig. 3c)
was observed in WT and Ins2Akita mice 40 days following
capsulotomy compared with corneal incision and full con-
trol mice (Fig. 3c). The above increase in immune retinal
cell infiltration in capsulotomy eyes was concomitant with
exacerbated reactive gliosis (GFAP; Fig. 3d) from the gan-
glion cell layer (GCL) to the OPL (GCL-OPL) of WT and
Ins2Akita mice (compared with full control and corneal
incision groups; Fig. 3d).
To understand whether retinal inflammation precedes
capsulotomy-induced retinal degeneration, we examined in-
flammatory gene expression by qPCR by 14 days post sur-
gery. This analysis revealed a significant upregulation of Il-1β
mRNA in the retina of Ins2Akita mice 14 days after
capsulotomy compared with non-surgery controls (Fig. 3e).
Ccl2 mRNA levels were below the level of detection in full
control WT and Ins2Akita retinas, becoming detectable follow-
ing surgery.
Capsulotomy significantly increased Ccl2 mRNA expres-
sion in Ins2Akita (p < 0.05, Fig. 3f) but not WT (p = 0.054)
mice. No significant changes in the mRNA levels of Vegfa
and iNos were detected in surgery eyes (Fig. 3g, h).
Immunohistochemistry staining revealed increased albumin
in retinal parenchyma in mice at 10 days post surgery but
not 40 days, suggesting transient blood–retinal barrier break-
down (ESM Fig. 3).
The canonical Wnt signalling pathway is activated in eyes of
Ins2Akita diabetic mice following capsulotomy Activation of
the canonical Wnt/β-catenin signalling pathway is known to
be involved in various inflammatory responses, including ret-
inal inflammation in diabetic retinopathy [33]. We therefore
investigated whether this pathway is activated in immune cells
following capsulotomy. Resembling those giant pigmented
cells at the retina (Fig. 3c), capsulotomy in Cx3cr1+/GFP mice
revealed the accumulation of nuclear β-catenin in GFP+
monocyte-derived cells at the irido–corneal junction (Fig.
4b), vitreo–retinal border (Fig. 4c) and subretinal space
(arrow in Fig. 4d). Interestingly, resident GFP+ microglial
cells showed negligible levels of nuclear β-catenin following
capsulotomy (arrow in Fig. 4e).
We next investigated the dynamics of Wnt/β-catenin
activation in ocular tissues following capsulotomy. For this
purpose, a detailed morphometric analysis was performed
to obtain: (1) the average levels of nuclear β-catenin (mea-
sured by mean fluorescence intensity [MFI]; ESM Fig. 4a);
and (2) the densities of cells accumulating low, mid and
high levels of nuclear β-catenin (ESM Fig. 4b). At the
irido–corneal junction, Ins2Akita mice showed a significant
increase in nuclear β-catenin levels in stromal cell popula-
tions by 1 day (Fig. 4f, p < 0.01) and 10 days (Fig. 4f, p <
0.01 [arrowheads show increase in area]) post surgery,
which declined to baseline levels by 40 days post surgery.
This was accompanied by a transient increase in the den-
sities of cells accumulating mid levels (1 day, p < 0.01) and
high levels (1 day, p < 0.05; 10 days, p < 0.001) of nuclear
β-catenin (Fig. 4f). WT mice showed no significant in-
crease in the average nuclear β-catenin values of stromal
cells (Fig. 4f). However, a transient increase in the densi-
ties of cells accumulating low (1 day post surgery, p <
0.05) and mid (10 day post surgery, p < 0.01) levels of
nuclear β-catenin was observed (Fig. 4f).
In the retina, no significant increases in the overall levels of
β-catenin were detected by western blot following
capsulotomy in WT or Ins2Akita mice (ESM Fig. 5).
However, the immunohistochemical morphometric analysis
revealed a rapid and significant upregulation of nuclear β-
catenin levels at the GCL (arrowheads in Fig. 4i) and inner
nuclear layer (INL) (arrowheads in Fig. 4h) of Ins2Akita mice.
These levels peaked by 10 days post surgery in both the INL
(Fig. 4h, p < 0.01) and GCL (Fig. 4i, p < 0.01), and remained
at high levels by 40 days. No significant upregulation of nu-
clear β-catenin was observed at the GCL or INL of WT mice
(Fig. 4h, i). Overall, these data suggest that the canonical Wnt
signalling pathway is activated in diabetic eyes following
capsulotomy.
Neutralisation of the canonical Wnt signalling pathway blunts
capsulotomy-induced ocular inflammation We then investi-
gated whether inhibiting canonical Wnt signalling could re-
duce capsulotomy-induced inflammation. WT and Ins2Akita
capsulotomy eyes were treated with monoclonal antibody
against the Wnt LRP6 co-receptor (Mab2F1) [27] or mouse
IgG isotype control (Fig. 5a). Mab2F1 treatment significantly
reduced the density of IBA1+ CD68+ infiltrating cells at the
irido–corneal junction, subretinal space and vitreo–retinal bor-
der in both WT and Ins2Akita mice 40 days post surgery (Fig.
5b, c). Mab2F1 did not affect the density of retinal microglial
cells (Fig. 5d). This was consistent with the nuclear levels of
β-catenin in immune cells observed in Cx3cr1+/GFP mice
following capsulotomy (Fig. 4e). Furthermore, Mab2F1
downregulated surgery-induced upregulation of the nuclear
β-catenin levels in the GCL and INL in Ins2Akita mice
(p < 0.01; ESM Fig. 6).
Mab2F1 treatment ameliorates capsulotomy-induced retinal
neurodegeneration Treatment with Mab2F1 significantly
prevented the reduction of a- and b-wave scotopic ERG re-
sponses (Fig. 6a–f) and the capsulotomy-induced retinal
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thinning (SD-OCT, Fig. 6g). Immunohistochemistry showed
that treatment with Mab2F1 significantly prevented the
capsulotomy-induced shortening of cone outer segments in
Ins2Akita mice (cone arrestin; Fig. 6h). Synaptic boutons at
the OPL were preserved by Mab2F1 treatment in both WT
and Ins2Akita mice (calbindin; Fig. 6i). In addition, the
treatment preserved amacrine cells (GABAergic +
glycinergic; Fig. 6j) and RGCs (BRN3A; Fig. 6k) in
Ins2Akita mice. Overall, neutralisation of the canonical Wnt
signalling pathway by monoclonal antibody resulted in the
prevention of capsulotomy-induced retinal neurodegeneration
in the diabetic and non-diabetic context.
Fig. 5 Neutralisation of canonical Wnt/β-catenin signalling pathway by
LRP6 antibody suppresses capsulotomy-induced ocular inflammation.
(a) Wnt/β-catenin signalling pathway was neutralised by administration
of monoclonal antibody (Mab2F1) against the LRP6 co-receptor.
Mab2F1 or mouse IgG isotype control was administered in 3-month-
old WT and Ins2Akita mice following capsulotomy at day 0 (anterior
chamber) and at day 20 (vitreal chamber), and eyes were processed at
day 40 for immunohistochemical analysis. (b) The area of IBA1 and
CD68 at the irido–corneal junction in different treatment groups. (c)
The density of IBA1 and CD68 in cells at the subretinal space/vitreo–
retinal border in different treatment groups. Arrows indicate macrophage
infiltration at the subretinal space. (d) The density of IBA1+ retinal
microglial cells in different treatment groups. White bars, full control;
light grey bars, capsulotomy + IgG; dark grey bars, capsulotomy +
Mab2F1. n = 12 sclero–corneal images and n = 9 retinal sections per
strain and condition. Results are presented as mean ± SEM. *p < 0.05,
**p < 0.01 and ***p < 0.001 as shown. One-way ANOVA. Scale bars,
20 μm. APC, adenomatous polyposis coli protein; β-cat,β-catenin; caps,
capsulotomy; CB, ciliary body; CK1, casein kinase 1α; Corn, cornea;
DVL, Dishevelled; GK3, glycogen synthase kinase 3; IPL, inner plexi-
form layer; IS, inner segment; ONL, outer nuclear layer; ret, retina; TCF,
T-cell factor
Diabetologia
Discussion
In this study, we show that lens capsulotomy triggers inflam-
mation in the anterior and posterior eye segments, which is
associated with retinal neurodegeneration. We also show that
capsulotomy-induced ocular inflammation and retinal neuro-
degeneration is worsened in the diabetic context, as observed
in Ins2Akita mice. Furthermore, our data suggest capsulotomy-
induced retinal neurodegeneration is driven by ocular inflam-
mation through Wnt/β-catenin signalling. Consequently,
blocking this pathway alleviated capsulotomy-induced retinal
neurodegeneration in WT and Ins2Akita mice.
Although the immune cell phenotype remains elusive, lens
capsulotomy promoted the infiltration of IBA1+ CD68+ cells
at the irido–corneal junction. Clinically, cataract-surgery-
induced inflammation is characterised by flare and immune
cell infiltration of the anterior chamber and the presence of
pro-inflammatory chemokines, including IL-1β in the aque-
ous humour [34, 35]. Cataract-surgery-induced immune re-
sponse at the posterior eye segment has not been investigated
Fig. 6 The effect of Mab2F1 in capsulotomy-induced retinal degenera-
tion.Mab2F1 ormouse IgG isotype control was administered in 3-month-
old WT and Ins2Akita mice following capsulotomy at day 0 (anterior
chamber) and at day 20 (intravitreal). At 40 days after the procedure, eyes
were assessed for retinal function (ERG) and retinal degeneration (SD-
OCT and analysis of neuronal morphometry). (a, b) Representative sco-
topic ERG responses from WT (a) and Ins2Akita (b) mice. (c–f) The
amplitude (μV) of scotopic a-wave (c, d) and b-wave (e, f) in WT (c, e)
and Ins2Akita (d, f) mice of different treatment groups. (g) Quantitative
analysis of neuroretinal thickness by SD-OCT inWTand Ins2Akitamice in
different treatment groups, with representative SD-OCT images among
the different Ins2Akita treatment groups. (h) The length of cone photore-
ceptor segments (cone arrestin) and the densities of (i) horizontal cell
synaptic boutons (calbindin), (j) amacrine cells (GABAergic +
glycinergic) and (k) retinal ganglion cells (BRN3A) in WT and Ins2Akita
mice of different treatment groups, with representative confocal
micrographs of the different Ins2Akita treatment groups shown below each
graph. In (c–f): solid line, full control; dashed line, capsulotomy + IgG;
dotted line, capsulotomy + Mab2F1. In (g and h–k): white bars, full
control; light grey bars, capsulotomy + IgG; dark grey bars, capsulotomy
+ Mab2F1. For ERG and SD-OCT (c–g), n = 7 for WT full controls and
n = 5 for WT and Ins2Akita remaining groups. For neuronal morphometry
(h–k), n = 24 retinal images per strain and condition. ERG white light
flashes are presented as log10 cd × s/m2. Results are presented as mean ±
SEM. (c–f) *p < 0.05, **p < 0.01 and ***p < 0.001 compared with full
control or IgG-treated mice of same strain. (e–f) †p < 0.05 between WT
and Ins2Akita IgG groups. (h–k) **p < 0.01 and ***p < 0.001 as shown.
Two-way ANOVA used in (c–f) and one-way ANOVA in (g–k). Scale
bars, 200 μm in (g) and 20 μm in (h–k). Calb, calbindin; c-arrest, cone
arrestin; caps, capsulotomy; ctrol, control; GlyT1, glycine transporter 1;
IPL, inner plexiform layer; IS, inner segment; ONL, outer nuclear layer;
OS, outer segment
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clinically. In this study, we have shown that lens capsulotomy
triggered retinal inflammation, characterised by infiltration of
IBA1+ CD68+ cells at the subretinal space and vitreo–retinal
border, increase in retinal microglial cells and upregulation of
pro-inflammatory gene expression. Previously, we reported
the upregulation of inflammatory mediators such as chemo-
kine [C-C motif] ligand 2 (CCL2), IL-1β and complement
proteins following extracapsular lens extraction in mice [19].
In this study, lens capsulotomy marginally increased Ccl2 but
not Il-1β expression in WT mouse retina. This discrepancy
may reflect theminimal surgical insult of capsulotomy surgery
compared with extracapsular lens extraction, as ocular inflam-
mation with cataract surgery is related to surgical trauma [18].
Unsurprisingly, capsulotomy-induced retinal inflammation
was further exacerbated in Ins2Akita mice, featured by IL-1β
upregulation. The upregulation of this chemokine is crucial,
given its critical role in inflammation [36]. A chronic low-
grade inflammation, including upregulation of cytokines and
chemokines, is known to exist in the diabetic retina [3, 5].
Such a pre-existing condition may therefore exacerbate
capsulotomy-mediated retinal inflammation.
Capsulotomy in 3-month-old Ins2Akita diabetic mice trig-
gered early onset of diabetic retinopathy-related neurodegen-
eration, including the disruption of synaptic structures at the
OPL and loss of amacrine cells and RGCs [30]. This may be
related to increased inflammation (e.g. higher Il-1β expres-
sion) in diabetic eyes as inflammatory mediators are known
to have detrimental effects on retinal neurons. Infiltrating im-
mune cells may play a critical role in this process through the
secretion of various proinflammatory cytokines and growth
factors [20, 37]. Accordingly, retinal damagewas significantly
alleviated in WT and Ins2Akita Mab2F1-treated eyes, which
displayed reduced immune cell infiltration in the anterior
and posterior eye segments following capsulotomy.
Activation of Wnt/β-catenin signalling is shown to exert a
detrimental effect in capsulotomy-induced retinal damage.
Consequently, capsulotomy-induced retinal damage in WT
and Ins2Akita mice was prevented by Mab2F1 treatment. In
diabetic retinopathy, previous investigations have suggested
thatWnt/β-catenin signallingmay play an immunopathogenic
role [21, 38]. Accordingly, upregulation of nuclear β-catenin
was exacerbated in the anterior and posterior eye segments of
Ins2Akitamice following lens capsulotomy. The precise role of
such upregulation is, however, uncertain. For example, at the
inflammatory level, activation of Wnt/β-catenin signalling is
known to exert proinflammatory functions [23, 39] and to be
activated in macrophages during the early stages of wound
repair [40]. Hence, the observation of increased nuclear β-
catenin in monocyte-derived cells shortly after capsulotomy
at the irido–corneal junction, subretinal space and vitreo–ret-
inal border is not surprising. Activation of Wnt/β-catenin in
the aforementioned immune cell subsets may induce inflam-
mation over tissue repair [23, 40], as validated by Mab2F1
treatment. These studies, including ours, suggest a potential
therapeutic effect in targeting Wnt/β-catenin signalling in di-
abetic individuals undergoing cataract surgery.
Previous studies have shown that activation of Wnt/β-
catenin in neurons is protective in the central nervous system
[41, 42]. The upregulation of nuclear β-catenin in non-
immune cells (likely neurons) in the Ins2Akita retina may thus
reflect a compensatory mechanism to favour neuronal surviv-
al. In line with this, in unpublished observations (Jose R.
Hombrebueno, Heping Xu) repeated intravitreal injection of
Mab2F1 failed to alleviate retinal neurodegeneration in full
control Ins2Akita mice, including abnormal scotopic ERG re-
sponses, SD-OCT retinal thinning and RGC degeneration.
Further, previous studies have shown that activation of Wnt/
β-catenin signalling via intravitreal injection with recombi-
nant Wnt3A induced RGC survival in a mouse model of axon
crush injury [43] and preservation of photoreceptors in a
mouse model of inherited retinal degeneration [44].
Nevertheless, a deleterious role of Wnt/β-catenin signalling
in retinal neurons cannot be completely disregarded [45].
Some factors may limit the translation of our study to clin-
ical practice. Phacoemulsification is the most common clinical
procedure for cataract surgery, but is impossible to perform in
the mouse eye. Extracapsular lens extraction was conducted
initially, but it triggered severe inflammation [19] and was
always followed by lens opacification [25]. Furthermore,
extracapsular lens extraction (without intraocular lens implan-
tation) is rarely performed in individuals with cataracts and
diabetes. The procedure was therefore discarded for this study.
We opted for small modifications to mimic cataract surgery by
phacoemulsification, such as the small surgical wound and
minimal disruption of lens structure. Interestingly, we ob-
served that the capsule re-sealed following surgery and the
lens maintained transparency after a prudent time (i.e.
20 days). The transient opacification of the cornea and lens
(lasting up to 10–15 days) following surgery prevented us
from conducting SD-OCT and fundus examinations during
that period. The SD-OCT measurement on day 40 after sur-
gery did not show any signs of retina oedema. Although we
detected albumin leakage, indicative of blood–retinal barrier
breakdown [46], the microscopic levels of leakage may not
cause significant retinal oedema. The lack of direct evidence
of surgery-induced retinal oedema in diabetic mouse eyes
makes it difficult to justify the value of this model to study
the mechanism of cataract-surgery-mediated macular oedema
in people with diabetes. This is another limitation of the study.
Finally, it is possible that the inflammation observed in the
anterior chamber could be partially due to the retained lens
fragments from ruptured capsule [47].
In summary, this study provides novel insights into
cataract-surgery-mediated retinal complications in diabetic
and non-diabetic individuals. This is of special importance,
given: (1) the absence of established guidelines for the
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postoperative treatment of inflammation induced by cataract
surgery [48]; (2) the limitation and adverse side effects of
current cataract surgery postoperative treatments
(corticosteroids) [49]; and (3) the contraindication of cataract
surgery in diabetes [50]. Despite the limitations of scaling
cataract surgery in the small mouse eyes, further study in large
animals or clinical trials will determine the suitability of
targeting the Wnt/β-catenin signalling pathway for the man-
agement of postoperative retinal complication in diabetes.
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